Mitchell B. Lowenstein

Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study

Graeme Jones, Anthony Sebba, Jianhui Gu et al. · Annals of the Rheumatic Diseases · 2009 · 809 citations · Full text

Medicine, Immunology, Pharmacotherapy +17

Ocrelizumab, a humanized anti‐CD20 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: A phase I/II randomized, blinded, placebo‐controlled, dose‐ranging study

Mark C. Genovese, Jeffrey Kaine, Mitchell B. Lowenstein et al. · Arthritis & Rheumatism · 2008 · 205 citations

Medicine, Pharmacology, Pharmacotherapy +16

Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study

Michael R. McClung, Michelle L. O’Donoghue, Socrates E. Papapoulos et al. · The Lancet Diabetes & Endocrinology · 2019 · 169 citations

Pharmacy, Pharmacotherapy, Bone Metabolism +10

Oral mucosal ulceration in systemic lupus erythematosus

Jeffrey D. Urman, Mitchell B. Lowenstein, Micha Abeles et al. · Arthritis & Rheumatism · 1978 · 95 citations

Medicine, Immunology, Pathology +17

Systemic lupus erythematosus in the younger patient: survival studies.

Micha Abeles, Jeffrey D. Urman, Arthur Weinstein et al. · PubMed · 1980 · 51 citations

Life Sciences, Immunology, Nephrology +11